#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-small cell lung cancer Juvenile chronic myelomonocytic leukaemia Isodicentric chromosome 15 syndrome Osteosarcoma recurrent Marginal zone lymphoma recurrent MELAS syndrome Oesophageal adenocarcinoma stage II Muscular dystrophy Turner's syndrome Fragile X syndrome Tourette's disorder Neonatal asphyxia Colon cancer Neoplasm Indolent systemic mastocytosis More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Trials in Disease Burkitt’s lymphoma – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent Synovial sarcoma recurrent Lymphangioma – Basic Information Biotinidase deficiency – Treatment Acquired haemophilia – Treatment Metachromatic leukodystrophy – Basic Information Basal cell naevus syndrome Lymphatic malformation More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Exenatide 4-Hydroxy-N-Desmethyltamoxifen Adct-402 Methoxsalen Cabazitaxel Lithium Carbonate Inupadenant Vgl101 Narsoplimab IDP-121 Anitocabtagene Autoleucel Terlipressin Acetate ZILEBESIRAN TEDUGLUTIDE VELPATASVIR Acp-017 Florbetaben (18F) LINAPRAZAN GLURATE Dabrafenib Mesylate Irinotecan More therapies…

    Learn about Your Condition

    Choroidal neovascularisation Dyspepsia Chronic lymphocytic leukaemia Von Willebrand's disease Strongyloidiasis Menopausal symptoms Spinal osteoarthritis Diabetic retinopathy Diabetic nephropathy Small cell lung cancer Plasmablastic lymphoma Stem cell transplant Cervix carcinoma stage II Endocarditis Psychological trauma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Atrial fibrillation

  • Study on Edoxaban for Patients with Atrial Fibrillation and Previous Brain Bleeding

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Edoxaban
    Austria Belgium Czechia Denmark Germany Greece +4

  • Study on Flecainide and Ranolazine for Restoring Heart Rhythm in Patients with Recent Atrial Fibrillation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Flecainide Acetate
    • Ranolazine
    Greece

  • Study of Rivaroxaban versus standard care in patients with excessive atrial ectopy or short atrial runs who have high risk of blood clots

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Lactose Monohydrate
    • Rivaroxaban
    France

  • Study on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolic stroke
    • Atrial fibrillation
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Rivaroxaban
    Belgium Germany

  • Study on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Abelacimab
    • Rivaroxaban
    Czechia Hungary Poland

  • Study on Early Ablation and Use of Amiodarone, Beta-Blockers, or Sotalol for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Bisoprolol Fumarate
    • Metoprolol Tartrate
    • Sotalol Hydrochloride
    Poland
Previous Page
1 … 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!